Volume 2, Issue 2 (Winter 2010)                   Iranian Journal of Blood and Cancer 2010, 2(2): 87-90 | Back to browse issues page

XML Print


Abstract:   (10618 Views)
Background: In the past 20 years, a dramatic improvement in the prognosis of patients with hepatoblastoma (HB)
has been achieved by combining surgery and chemotherapy in several national and international trials.
Materials and Methods: Four children ( 3 girl and 1 boy) aged 34 days, 4 months, 13 months, and 1 year with mean
age of 6.53 (±5.15) months were presented to our center from 2002 to 2009 with abdominal mass and abdominal
distention. Their abdominal ultrasonography revealed liver mass, and pathological diagnosis was hepatoblasma.
They were treated with a combination of surgery and chemotherapy.
Results: Patients with non-metastatic HB were treated at Shahid Sadoughi Hospital of Yazd. A complete resection of
primary tumor was achieved in all of them. The median follow- up of the patients was 38.25 (± 29.02) month and all
of them (100%) remained alive with complete remission.
Conclusion: Complete resection with chemotherapy can improve prognosis of hepatoblastoma patients.
Full-Text [PDF 503 kb]   (4562 Downloads)    
: Original Article | Subject: Pediatric Hematology & Oncology
Received: 2011/03/12 | Published: 2010/02/15

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.